PARATHYROID-HORMONE SECRETORY RESERVE IN PATIENTS SUBMITTED TO 131-IODINE THERAPY FOR HYPERTHYROIDISM

Fecha
1991-01-01Autor
Vieira, Jose Gilberto Henriques [UNIFESP]
Brandao, Cynthia Maria Alvares [UNIFESP]
Kasamatsu, Teresa Sayoko [UNIFESP]
Furlanetto, Reinaldo Perrone [UNIFESP]
Tipo
ArtigoISSN
0100-879XEs parte de
Brazilian Journal Of Medical And Biological ResearchMetadatos
Mostrar el registro completo del ítemResumen
Twelve euthyroid patients who had been treated with I-131 for hyperthyroidism due to Graves' disease and six normal controls were submitted to an EDTA infusion test. Ionized calcium and parathyroid hormone were measured in serum samples collected every 10 min during the 2-h test. Basal values for calcium (1.22 +/- 0.03 vs 1.23 +/- 0.03 pmol/l, mean +/- SD, controls vs patients) and parathyroid hormone (3.3 +/- 0.65 vs 5.1 +/- 2.32 pmol/l) as well as maximum response during infusion (1.01 +/- 0.04 vs 1.01 +/- 0.05 for calcium and 12.0 +/- 2.2 vs 13.1 +/- 3.7 for parathyroid hormone) were not significantly different. We conclude that I-131 treatment for hyperthyroidism due to Graves' disease had no effect on the parathyroid gland secretory reserve of the patients studied.
Cita
Brazilian Journal Of Medical And Biological Research. Sao Paulo: Assoc Bras Divulg Cientifica, v. 24, n. 11, p. 1103-1105, 1991.Palabras clave
PARATHYROID HORMONEI-131 THERAPY
EDTA-INDUCED HYPOCALCEMIA
HYPERTHYROIDISM
GRAVES DISEASE
Colecciones
- EPM - Artigos [17709]